Exicure, Inc. SEC filings XCUR
Exicure, Inc. has 532 filings in SEC EDGAR's recent list, going back to Mar 21, 2017. Its latest annual report, Form 10-K, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 16, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| PRE 14A | Preliminary proxy statement | Nov 2, 2026 | Dec 2, 2026 |
| DEF 14A | Proxy statement | Sep 23, 2025 | Sep 23, 2025 |
| DEF 14A | Proxy statement | Dec 2, 2024 | Dec 2, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 22, 2024 | Nov 22, 2024 |
| DEF 14A | Proxy statement | Jul 30, 2024 | Jul 30, 2024 |
| PRE 14A | Preliminary proxy statement | Jul 19, 2024 | Jul 19, 2024 |
| DEF 14A | Proxy statement | Jun 11, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Dec 14, 2022 | — |
| DEFA14A | Additional proxy material | Nov 14, 2022 | — |
| DEF 14A | Proxy statement | Nov 10, 2022 | Dec 15, 2022 |
| PRE 14A | Preliminary proxy statement | Oct 31, 2022 | Dec 15, 2022 |
| DEFA14A | Additional proxy material | Apr 12, 2022 | — |
| DEF 14A | Proxy statement | Apr 12, 2022 | May 27, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 1, 2022 | May 27, 2022 |
| DEFA14A | Additional proxy material | Apr 22, 2021 | — |
| DEF 14A | Proxy statement | Apr 22, 2021 | Jun 1, 2021 |
| DEFA14A | Additional proxy material | Apr 21, 2020 | — |
| DEF 14A | Proxy statement | Apr 21, 2020 | Jun 3, 2020 |
| DEF 14A | Proxy statement | Apr 30, 2019 | Apr 30, 2019 |
| DEFA14A | Additional proxy material | Apr 30, 2018 | — |
| DEF 14A | Proxy statement | Apr 30, 2018 | Jun 19, 2018 |
| DEF 14C | Information statement | Oct 26, 2017 | Oct 26, 2017 |
| PRE 14C | Filing | Oct 16, 2017 | Oct 16, 2017 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XCUR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Chicago, IL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1698530
- Former names
- Max-1 Acquisition Corp (until Sep 28, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.